Clinical Trial Update: CLUE: CLinical Utility Study of EsoGuard [NA]

View source ↗

Summary

The CLUE study evaluating the clinical utility of EsoGuard for Barrett's esophagus and related conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Barrett Esophagus with Dysplasia
• Esophageal Adenocarcinoma

Snippet

Sponsor: Lucid Diagnostics, Inc. | Conditions: Barrett Esophagus, Barretts Esophagus With Dysplasia | NA | Status: COMPLETED